Log in
Enquire now

List of Orexo patents

List of Orexo patents
List of Ivera Medical patents
List of Lord Corporation patents
List of Northeastern University patents
List of SBIR/STTR awards granted to Triple Ring Technologies
Virtual reality venture capital investors
Patents where
Current Assignee
Name
is
OrexoOrexo
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 10898480 Pharmaceutical composition for nasal delivery

Patent 10898480 was granted and assigned to Orexo on January, 2021 by the United States Patent and Trademark Office.

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
10898480
January 26, 2021
‌
US Patent 7815940 Gastric acid secretion inhibiting composition

Patent 7815940 was granted and assigned to Orexo on October, 2010 by the United States Patent and Trademark Office.

Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
7815940
October 19, 2010
‌
US Patent 11433066 Abuse-resistant pharmaceutical composition for the treatment of opioid dependence

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
11433066
September 6, 2022
‌
US Patent 8658198 Non-abusable pharmaceutical composition comprising opioids

Patent 8658198 was granted and assigned to Orexo on February, 2014 by the United States Patent and Trademark Office.

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
8658198
February 25, 2014
‌
US Patent 11617746 Method of controlling depression in subjects treated for opioid dependence

Patent 11617746 was granted and assigned to Orexo on April, 2023 by the United States Patent and Trademark Office.

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
11617746
April 4, 2023
‌
US Patent 10653690 Pharmaceutical composition for nasal delivery

Patent 10653690 was granted and assigned to Orexo on May, 2020 by the United States Patent and Trademark Office.

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
10653690
May 19, 2020
‌
US Patent 9345698 Alfentanil composition for the treatment of acute pain

Patent 9345698 was granted and assigned to Orexo on May, 2016 by the United States Patent and Trademark Office.

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
9345698
May 24, 2016
‌
US Patent 9597281 Pharmaceutical formulations useful in the treatment of insomnia

Patent 9597281 was granted and assigned to Orexo on March, 2017 by the United States Patent and Trademark Office.

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
9597281
March 21, 2017
‌
US Patent 9782396 Alfentanil composition for the treatment of acute pain

Patent 9782396 was granted and assigned to Orexo on October, 2017 by the United States Patent and Trademark Office.

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
9782396
October 10, 2017
‌
US Patent 10729687 Pharmaceutical composition for nasal delivery

Patent 10729687 was granted and assigned to Orexo on August, 2020 by the United States Patent and Trademark Office.

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
10729687
August 4, 2020
‌
US Patent 7785626 Gastric acid secretion inhibiting composition

Patent 7785626 was granted and assigned to Orexo on August, 2010 by the United States Patent and Trademark Office.

Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
7785626
August 31, 2010
‌
US Patent 9265720 Pharmaceutical formulations useful in the treatment of insomnia

Patent 9265720 was granted and assigned to Orexo on February, 2016 by the United States Patent and Trademark Office.

Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
9265720
February 23, 2016
‌
US Patent 10946010 Abuse-resistant pharmaceutical composition for the treatment of opioid dependence

Patent 10946010 was granted and assigned to Orexo on March, 2021 by the United States Patent and Trademark Office.

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
10946010
March 16, 2021
‌
US Patent 8940330 Abuse-resistant pharmaceutical composition for the treatment of opioid dependence

Patent 8940330 was granted and assigned to Orexo on January, 2015 by the United States Patent and Trademark Office.

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
8940330
January 27, 2015
‌
US Patent 8980305 Non-abusable pharmaceutical composition comprising opioids

Patent 8980305 was granted and assigned to Orexo on March, 2015 by the United States Patent and Trademark Office.

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
8980305
March 17, 2015
‌
US Patent 10874661 Abuse-resistant pharmaceutical composition for the treatment of opioid dependence

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
10874661
December 29, 2020
‌
US Patent 9439900 Abuse-resistant pharmaceutical composition for the treatment of opioid dependence

Patent 9439900 was granted and assigned to Orexo on September, 2016 by the United States Patent and Trademark Office.

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
9439900
September 13, 2016
‌
US Patent 9408843 Abuse-resistant pharmaceutical composition for the treatment of opioid dependence

Patent 9408843 was granted and assigned to Orexo on August, 2016 by the United States Patent and Trademark Office.

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
9408843
August 9, 2016
‌
US Patent 8815911 Alfentanil composition for the treatment of acute pain

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
8815911
August 26, 2014
‌
US Patent 9259421 Abuse-resistant pharmaceutical composition for the treatment of opioid dependence

Patent 9259421 was granted and assigned to Orexo on February, 2016 by the United States Patent and Trademark Office.

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
9259421
February 16, 2016
‌
US Patent 8454996 Pharmaceutical composition for the treatment of acute disorders

Patent 8454996 was granted and assigned to Orexo on June, 2013 by the United States Patent and Trademark Office.

Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
8454996
June 4, 2013
‌
US Patent 11020388 Abuse-resistant pharmaceutical composition for the treatment of opioid dependence

Patent 11020388 was granted and assigned to Orexo on June, 2021 by the United States Patent and Trademark Office.

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
11020388
June 1, 2021
‌
US Patent 8821914 Non-abusable pharmaceutical composition comprising opioids

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
8821914
September 2, 2014
‌
US Patent 11020387 Abuse-resistant pharmaceutical composition for the treatment of opioid dependence

Patent 11020387 was granted and assigned to Orexo on June, 2021 by the United States Patent and Trademark Office.

Orexo
Orexo
Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
11020387
June 1, 2021
‌
US Patent 7771747 Gastric acid secretion inhibiting composition

Patent 7771747 was granted and assigned to Orexo on August, 2010 by the United States Patent and Trademark Office.

Orexo
Orexo
United States Patent and Trademark Office
United States Patent and Trademark Office
7771747
August 10, 2010
Results per page:
30 results
0 selected
30 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us